TautermannCS, KiechleT, SeeligerD, et al.: Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor. J Med Chem, 2013; 56:8746–8756.
2.
BirrellMA, BonviniSJ, DubuisE, et al.: Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: a beneficial off-target effect?. J Allergy Clin Immunol, 2014; 133:679.e9–687.e9.
3.
ToumpanakisD, LoverdosK, TzoudaV, et al.: Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction. Int J Chron Obstruct Pulmon Dis, 2017; 12:2207–2220.
4.
ElshalAM, AtwaAM, El-NahasAR, et al.: Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial. World J Urol, 2018; 36:1845–1852.
5.
Valdevenito SepúlvedaJP: Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study [in Spanish]. Arch Esp Urol, 2004; 57:48–57.
6.
DonadieuJ, BeaupainB, FenneteauO, Bellanné-ChantelotC: Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. Br J Haematol, 2017; 179:557–574.
7.
KleinC: Congenital neutropenia. Hematology Am Soc Hematol Educ Program, 2009:344–350.
8.
Veiga-da-CunhaM, ChevalierN, StephenneX, et al.: Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A, 2019; 116:1241–1250.
9.
TunekA, SvenssonLA: Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood. Drug Metab Dispos, 1988; 16:759–764.
10.
KovarikZ, Simeon-RudolfV: Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline. J Enzyme Inhib Med Chem, 2004; 19:113–117.
11.
RealeM, Di NicolaM, VellutoL, et al.: Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr Alzheimer Res, 2014; 11:608–622.
12.
XuH, RajsombathMM, WeikopP, SelkoeDJ: Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β. EMBO Mol Med, 2018; 10:pii:e8931.
13.
LyonJA: Imipenem/cilastatin: the first carbapenem antibiotic. Drug Intell Clin Pharm, 1985; 19:895–899.
HoriY, AokiN, KuwaharaS, HosojimaM, KasedaR, GotoS: Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J Am Soc Nephrol, 2017; 28:1783–1791.
16.
KukidaM, SawadaH, DaughertyA, LuHS: Megalin: a bridge connecting kidney, the renin-angiotensin system, and atherosclerosis. Pharmacol Res, 2020; 151:104537.
17.
KnudsenLF, TerkelsenAJ, DrummondPD, BirkleinF: Complex regional pain syndrome: a focus on the autonomic nervous system. Clin Auton Res, 2019; 29:457–467.
18.
BrunnerF, SchmidA, KisslingR, HeldU, BachmannLM: Biphosphonates for the therapy of complex regional pain syndrome I—systematic review. Eur J Pain, 2009; 13:17–21.
19.
VarennaM, CrottiC: Bisphosphonates in the treatment of complex regional pain syndrome: is bone the main player at early stage of the disease?. Rheumatol Int, 2018; 38:1959–1962.
20.
BrodziakA, ZiółkoE, Muc-WierzgońM, et al.: The role of human endogenous retroviruses in the pathogenesis of autoimmune diseases. Med Sci Monit, 2012; 18:RA80–RA88.
21.
NevalainenT, AutioA, MishraBH, MarttilaS, JylhäM, HurmeM: Aging-associated patterns in the expression of human endogenous retroviruses. PLoS One, 2018; 13:e0207407.
22.
FaulknerGJ, BillonV: L1 retrotransposition in the soma: a field jumping ahead. Mob DNA, 2018; 9:22.
23.
HuN, GaoY, JayasuriyaCT, et al.: Chondrogenic induction of human osteoarthritic cartilage-derived mesenchymal stem cells activates mineralization and hypertrophic and osteogenic gene expression through a mechanomiR. Arthritis Res Ther, 2019; 21:167.
24.
TeerawattanapongN, UdomsinprasertW, NgarmukosS, TanavaleeA, HonsawekS: Blood leukocyte LINE-1 hypomethylation and oxidative stress in knee osteoarthritis. Heliyon, 2019; 5:e01774.
25.
BrandsmaD, BrombergJEC: Primary CNS lymphoma in HIV infection. Handb Clin Neurol, 2018; 152:177–186.
26.
McGowanPM, SimedreaC, RibotEJ, et al.: Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. Mol Cancer Res, 2011; 9:834–844.
27.
Danish RizviSM, HussainT, SubaieaGM, ShakilS, AhmadA: Therapeutic targeting of amyloid precursor protein and its processing enzymes for breast cancer treatment. Curr Protein Pept Sci, 2018; 19:841–849.
28.
PandeyP, SlikerB, PetersHL, et al.: Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget, 2016; 7:19430–19444.
29.
VioliF, GhiselliA, IulianoL, PraticòD, AlessandriC, BalsanoF: Inhibition by picotamide of thromboxane production in vitro and ex vivo. Eur J Clin Pharmacol, 1988; 33:599–602.
30.
LandolfiR, CastellanaMA, De CristofaroR, De CandiaE, BizziB: Effect of picotamide on prostacyclin production by human endothelial cells. Thromb Haemost, 1988; 60:529.
31.
VezzaR, SpinaD, TallaridaRJ, NathanM, PageCP, GreseleP: Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. Thromb Haemost, 1997; 78:1385–1391.
32.
GaoZ, XuZ, HungMS, et al.: Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells. Oncol Rep, 2009; 22:1479–1484.
33.
ZambranoP, Segura-PachecoB, Perez-CardenasE, et al.: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer, 2005; 5:44.
34.
MilutinovicS, D'AlessioAC, DetichN, SzyfM: Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis, 2007; 28:560–571.
35.
HannumG, GuinneyJ, ZhaoL, et al.: Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell, 2013; 49:359–367.
36.
AlufY, VayaJ, KhatibS, LobodaY, FinbergJP: Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology, 2013; 65:48–57.
